BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11241260)

  • 1. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases.
    Krane JF; Granter SR; Trask CE; Hogan CL; Lee KR
    Cancer; 2001 Feb; 93(1):8-15. PubMed ID: 11241260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin.
    Simsir A; Hwang S; Cangiarella J; Elgert P; Levine P; Sheffield MV; Roberson J; Talley L; Chhieng DC
    Cancer; 2003 Dec; 99(6):323-30. PubMed ID: 14681938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
    Sherman ME; Kelly D
    Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears.
    Novotny DB; Maygarden SJ; Johnson DE; Frable WJ
    Acta Cytol; 1992; 36(1):1-10. PubMed ID: 1546503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ; Kenny MB; Naib ZM
    Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases.
    Lee KR; Minter LJ; Granter SR
    Am J Clin Pathol; 1997 Jan; 107(1):30-5. PubMed ID: 8980364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocervical glandular atypia in Papanicolaou smears.
    Goff BA; Atanasoff P; Brown E; Muntz HG; Bell DA; Rice LW
    Obstet Gynecol; 1992 Jan; 79(1):101-4. PubMed ID: 1727566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of MiB-1 staining in smears with atypical glandular cells.
    Boon ME; Vinkestein A; van Binsbergen-Ingelse A; van Haaften C
    Diagn Cytopathol; 2004 Aug; 31(2):77-82. PubMed ID: 15282717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the uterine cervix: cytologic findings in 13 cases.
    Zhou C; Hayes MM; Clement PB; Thomson TA
    Cancer; 1998 Oct; 84(5):281-8. PubMed ID: 9801202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
    Kristensen GB; Skyggebjerg KD; Hølund B; Holm K; Hansen MK
    Acta Cytol; 1991; 35(1):47-50. PubMed ID: 1994634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
    Pretorius R; Binstock M; Sadeghi M; Hodges W
    J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-negative results in cervical cytologic studies.
    Gay JD; Donaldson LD; Goellner JR
    Acta Cytol; 1985; 29(6):1043-6. PubMed ID: 3866457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Applicative aspects of liquid-based cytology in cervical cancer screening].
    Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
    Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of diagnoses of endocervical glandular abnormalities in cervical smears.
    Segal A; Frost FA; Miranda A; Fletcher C; Sterrett GF
    Pathology; 2003 Jun; 35(3):198-203. PubMed ID: 14506961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of post-trachelectomy isthmic and vaginal smear cytology.
    Singh N; Titmuss E; Chin Aleong J; Sheaff MT; Curran G; Jacobs IJ; Shepherd JH
    Cytopathology; 2004 Apr; 15(2):97-103. PubMed ID: 15056170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.